Title |
The BCTRIMS expanded consensus on treatment of multiple sclerosis: II. The evidences for the use of glucocorticoids and immunomodulatory treatments
|
---|---|
Published in |
Arquivos de Neuro-Psiquiatria, October 2002
|
DOI | 10.1590/s0004-282x2002000500036 |
Pubmed ID | |
Authors |
Marcos Aurélio Moreira, Marco Aurélio Lana-Peixoto, Dagoberto Callegaro, Sérgio Roberto Haussen, Paulo Diniz Gama, Alberto Alain Gabbai, Fernando Coronetti Gomes Rocha, Angelina Maria Martins Lino |
Abstract |
Multiple sclerosis is an inflammatory disease in which immunological mechanisms play an important role in causing demyelinating lesions in the central nervous system. A number of drugs acting in different stages of these mechanisms have been tested for its treatment. This paper analyses the most important clinical trials with glucocorticoids and immunomodulatory treatments, including human immunoglobulin, using the classes of evidences and types of recommendations as have been defined and widely accepted by the international scientific community. It aims to provide sufficient information to support the BCTRIMS Expanded Consensus on Treatment of MS. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 13% |
Unknown | 7 | 88% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Professor > Associate Professor | 4 | 50% |
Student > Ph. D. Student | 1 | 13% |
Student > Bachelor | 1 | 13% |
Student > Doctoral Student | 1 | 13% |
Unknown | 1 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Social Sciences | 2 | 25% |
Medicine and Dentistry | 2 | 25% |
Agricultural and Biological Sciences | 1 | 13% |
Biochemistry, Genetics and Molecular Biology | 1 | 13% |
Neuroscience | 1 | 13% |
Other | 0 | 0% |
Unknown | 1 | 13% |